Amara K, Trimeche M, Baccouche D, Ziadi S, Sriha B, Korbi S
Laboratoire d'anatomie et de cytologie pathologiques, CHU Farhat Hached de Sousse, Tunisie.
Ann Biol Clin (Paris). 2005 Jan-Feb;63(1):75-81.
To study the lymphoid clonality on Tunisian B-cell lymphomas cases by polymerase chain reaction (PCR)-based techniques using DNA from paraffin-embedded tissues.
Here we conducted a retrospective PCR clonality study on 73 cases of B-cell lymphomas and 12 reactive lymphoid tissues. The quality of DNA extracted was tested by beta-globin PCR. Consensus primers directed at the FRIII-VH and FRII-VH regions of the immunoglobulin heavy chain (IgH) gene were used to detect clonality.
The results showed that 52 of 73 (71%) B-cell lymphomas exhibited good quality of amplifiable DNA. Clonality was found in 77% of cases using the set of primers FRIIIa/LJH/VLJH and in 65.5% using the set of primers FRIIa/LJH/VLJH. Lymphomas derived from pregerminal centre showed a high rate detection of clonal IgH gene rearrangement (100%) compared to other group of tumors derived from germinal centre or postgerminal centre (74.5%). None of the polyclonal controls gave a clonal pattern.
This is the first large series of PCR clonality study of IgH gene rearrangements on B-cell lymphoma from Tunisia. Our results were similar to other reports in terms of sensitivity and specificity of these techniques and confirm the interest of that PCR for detecting clonal IgH gene rearrangements in lymphoma.
运用基于聚合酶链反应(PCR)的技术,利用石蜡包埋组织中的DNA,研究突尼斯B细胞淋巴瘤病例中的淋巴细胞克隆性。
我们对73例B细胞淋巴瘤病例和12例反应性淋巴组织进行了回顾性PCR克隆性研究。通过β-珠蛋白PCR检测提取的DNA质量。使用针对免疫球蛋白重链(IgH)基因FRIII-VH和FRII-VH区域的共有引物检测克隆性。
结果显示,73例(71%)B细胞淋巴瘤中有52例呈现出可扩增DNA的良好质量。使用引物组FRIIIa/LJH/VLJH时,77%的病例检测到克隆性;使用引物组FRIIa/LJH/VLJH时,65.5%的病例检测到克隆性。与源自生发中心或生发中心后其他肿瘤组相比,源自生发中心前的淋巴瘤克隆性IgH基因重排的检测率较高(100%)。所有多克隆对照均未呈现克隆模式。
这是突尼斯关于B细胞淋巴瘤IgH基因重排的首个大规模PCR克隆性研究系列。就这些技术的敏感性和特异性而言,我们的结果与其他报告相似,并证实了PCR在检测淋巴瘤中克隆性IgH基因重排方面的价值。